Date: 2016-08-04 23:26:02Piperazines Breakthrough therapy Nintedanib Boehringer Ingelheim Kasumigaseki Adverse effect Ministry of Health Labour and Welfare Package insert | | Pharmaceuticals and Medical Devices Agency This English version is intended to be a reference material for the convenience of users. In the event of inconsistency between the Japanese original and this English translatioAdd to Reading ListSource URL: www.pmda.go.jpDownload Document from Source Website File Size: 74,51 KBShare Document on Facebook
|